Diagnostic Utility of Hematological and Lipid Biomarkers in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
- 7 April 2026
- journal article
- research article
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- p. 1-8
Abstract
No abstract availableKeywords
Funding Information
- Banaras Hindu University (Institute of Eminence Cell, BHU, Varanasi)
This publication has 17 references indexed in Scilit:
- Role of Hematological Markers in Oral Potentially Malignant Disorders and Oral Squamous Cell CarcinomaIndian Journal of Otolaryngology and Head & Neck Surgery, 2023
- Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinomaBMC Oral Health, 2023
- Association Between Mean Platelet Volume, Platelet Count, and Distribution Width With Depth of Invasion in Oral CancersEar, Nose & Throat Journal, 2022
- Relationship between anemia and oral cancer: a case-control studyBrazilian Oral Research, 2021
- Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck CancerThe Laryngoscope, 2020
- Association of Increased Red Cell Distribution Width with Malignant Transformation of Oral Submucous FibrosisDental Journal of Advance Studies, 2019
- White blood cell count of patients with oral squamous cell carcinoma at the time of diagnosis: a cross-sectional retrospective study of a population from southern BrazilRevista Odonto Ciência, 2018
- An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinomaHead & Neck Oncology, 2011
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Relation of erythrocyte and iron indices to oral cancer growthRadiotherapy and Oncology, 2001